96 related articles for article (PubMed ID: 19666910)
21. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage.
Amann K; Simonaviciene A; Medwedewa T; Koch A; Orth S; Gross ML; Haas C; Kuhlmann A; Linz W; Schölkens B; Ritz E
J Am Soc Nephrol; 2001 Dec; 12(12):2572-2584. PubMed ID: 11729225
[TBL] [Abstract][Full Text] [Related]
22. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
23. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
Adamczak M; Gross ML; Amann K; Ritz E
J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
[TBL] [Abstract][Full Text] [Related]
24. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
25. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH
Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
[TBL] [Abstract][Full Text] [Related]
26. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers.
Amann K; Koch A; Hofstetter J; Gross ML; Haas C; Orth SR; Ehmke H; Rump LC; Ritz E
Kidney Int; 2001 Oct; 60(4):1309-23. PubMed ID: 11576345
[TBL] [Abstract][Full Text] [Related]
27. Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats.
Piecha G; Kokeny G; Nakagawa K; Koleganova N; Geldyyev A; Berger I; Ritz E; Schmitt CP; Gross ML
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F748-57. PubMed ID: 18199601
[TBL] [Abstract][Full Text] [Related]
28. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
Lim S
Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effect of combined spironolactone and quinapril treatment on thrombosis and hemostasis in 2K1C hypertensive rats.
Gromotowicz-Poplawska A; Stankiewicz A; Mikita J; Aleksiejczuk M; Marcinczyk N; Szemraj J; Chabielska E
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980144
[TBL] [Abstract][Full Text] [Related]
30. The Rowett rat strain is resistant to renal fibrosis.
Kökény G; Németh Z; Godó M; Hamar P
Nephrol Dial Transplant; 2010 May; 25(5):1458-62. PubMed ID: 20028828
[TBL] [Abstract][Full Text] [Related]
31. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.
Amann K; Törnig J; Flechtenmacher C; Nabokov A; Mall G; Ritz E
Nephrol Dial Transplant; 1995 Nov; 10(11):2043-8. PubMed ID: 8643165
[TBL] [Abstract][Full Text] [Related]
32. Spironolactone and ACE inhibition in chronic renal failure.
Epstein FH
N Engl J Med; 2002 Feb; 346(6):456-7. PubMed ID: 11832542
[No Abstract] [Full Text] [Related]
33. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.
Chrysostomou A; Becker G
N Engl J Med; 2001 Sep; 345(12):925-6. PubMed ID: 11565535
[No Abstract] [Full Text] [Related]
34. The role of Na+-H+ exchanger isoform 1 in aldosterone-induced glomerulosclerosis in vivo.
Zhang M; Chen J; Liu S; You L; Lin S; Gu Y
Ren Fail; 2009; 31(8):726-35. PubMed ID: 19814640
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model.
Kelly DJ; Zhang Y; Cox AJ; Gilbert RE
Kidney Int; 2006 Jun; 69(11):1954-60. PubMed ID: 16557218
[TBL] [Abstract][Full Text] [Related]
36. Cigarette smoke condensate aggravates renal injury in the renal ablation model.
Odoni G; Ogata H; Viedt C; Amann K; Ritz E; Orth SR
Kidney Int; 2002 Jun; 61(6):2090-8. PubMed ID: 12028449
[TBL] [Abstract][Full Text] [Related]
37. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
Amann K; Rump LC; Simonaviciene A; Oberhauser V; Wessels S; Orth SR; Gross ML; Koch A; Bielenberg GW; VAN Kats JP; Ehmke H; Mall G; Ritz E
J Am Soc Nephrol; 2000 Aug; 11(8):1469-1478. PubMed ID: 10906160
[TBL] [Abstract][Full Text] [Related]
38. Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats.
Schwarz U; Amann K; Orth SR; Simonaviciene A; Wessels S; Ritz E
Kidney Int; 1998 Jun; 53(6):1696-705. PubMed ID: 9607202
[TBL] [Abstract][Full Text] [Related]
39. Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats.
Morath C; Ratzlaff K; Dechow C; Schwenger V; Schaier M; Zeier B; Peters J; Tsukada M; Zouboulis CC; Waldherr R; Gross ML; Ritz E; Zeier M; Wagner J
J Mol Med (Berl); 2009 Jan; 87(1):53-64. PubMed ID: 18795249
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats.
Kökény G; Fang L; Révész C; Mózes MM; Vörös P; Szénási G; Rosivall L
Kidney Blood Press Res; 2017; 42(1):109-122. PubMed ID: 28359068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
